Is Trigyn Techno. overvalued or undervalued?

As of 4 November 2025, Trigyn Technologies has moved from a fair to an expensive valuation grade. The company is currently overvalued, as indicated by its significant negative PE ratio of -2487.77, an EV to EBITDA ratio of -26.45, and a Price to Book Value of 0.31. These ratios suggest that the company's earnings and cash flow metrics are not only poor but also reflect a lack of profitability.
When compared to its peers, Trigyn's valuation stands out unfavorably. For instance, TCS, which is rated as attractive, has a PE ratio of 21.51, while Infosys, rated as fair, has a PE of 21.68. Both companies demonstrate strong earnings potential compared to Trigyn's negative metrics. Additionally, the company's stock has underperformed the Sensex, with a year-to-date return of -30.70% compared to the Sensex's 6.81%. This further reinforces the notion that Trigyn Technologies is currently overvalued in the market.